Mostrar el registro sencillo del ítem
dc.contributor.author
Garay, Laura Ines
dc.contributor.author
Gonzalez Deniselle, Maria Claudia
dc.contributor.author
Sitruk Ware, Regine
dc.contributor.author
Gennoun, Rachida
dc.contributor.author
Shumacher, Michael
dc.contributor.author
Alejandro de Nicola
dc.date.available
2016-07-26T14:19:41Z
dc.date.issued
2014-11-15
dc.identifier.citation
Garay, Laura Ines; Gonzalez Deniselle, Maria Claudia; Sitruk Ware, Regine; Gennoun, Rachida; Shumacher, Michael; et al.; Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis; Elsevier Inc; Journal Of Neuroimmunology; 276; 1-2; 15-11-2014; 89-97
dc.identifier.issn
0165-5728
dc.identifier.uri
http://hdl.handle.net/11336/6680
dc.description.abstract
Progesterone plays a protective role in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis (MS). Besides spinal cord neuropathology, MS patients present a dysfunctional hippocampus. In this work we studied the therapeutic effects of the progestin Nestorone in the brain of mice with chronic EAE. Nestorone decreased clinical grade and enhanced motor behavior. In addition, it increased cell proliferation and doublecortin positive neuroblasts in the hippocampus, increased GABAergic interneurons and attenuated the number of Iba1+ microglia/macrophages, events possibly linked to enhancement of neurogenesis. Therefore, Nestorone protected against hippocampus abnormalities and improved functional outcomes of EAE mice, suggesting its potential value for MS.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Elsevier Inc
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.subject
Hippocampus
dc.subject
Gfap
dc.subject
Experimental Autoimmune Encephalomyelitis
dc.subject
Nestorone
dc.subject.classification
Neurociencias
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Efficacy of the selective progesterone receptor agonist Nestorone for chronic experimental autoimmune encephalomyelitis
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2016-06-15T19:08:38Z
dc.journal.volume
276
dc.journal.number
1-2
dc.journal.pagination
89-97
dc.journal.pais
Países Bajos
dc.journal.ciudad
Amsterdam
dc.description.fil
Fil: Garay, Laura Ines. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
dc.description.fil
Fil: Gonzalez Deniselle, Maria Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina
dc.description.fil
Fil: Sitruk Ware, Regine. Population Council’s Center for Biomedical Research; Estados Unidos. The Rockefeller University; Estados Unidos
dc.description.fil
Fil: Gennoun, Rachida. Inserm; Francia
dc.description.fil
Fil: Shumacher, Michael. Inserm; Francia
dc.description.fil
Fil: Alejandro de Nicola. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental (i); Argentina. Universidad de Buenos Aires. Facultad de Medicina. Departamento de Bioquímica Humana; Argentina
dc.journal.title
Journal Of Neuroimmunology
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jneuroim.2014.08.619
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.jneuroim.2014.08.619
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/pmid/25200475
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.sciencedirect.com/science/article/pii/S0165572814008686
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.jni-journal.com/article/S0165-5728(14)00868-6/abstract
Archivos asociados